67.下列何種抗生素醫囑最
不適當?
(A)ceftriaxone + doxycycline
(B)ampicillin/sulbactam + azithromycin
(C)clarithromycin + moxifloxacin
(D)levofloxacin
統計: A(1079), B(599), C(2828), D(1020), E(0) #1528198
詳解 (共 10 筆)
一般社區性肺炎→單用macrolides (azithromycin, clarithromycin or erythromyicn)或doxycycline
有共病症(慢性心肺肝腎疾病、DM、酗酒、惡性腫瘤、免疫抑制、可能感染抗藥性肺炎鏈球菌)
→單用FQ (moxi-, gemi-, levo)或β-lactam + macrolide
P.S.
使用macrolide通常是為了抗非典型肺炎(Mycoplasma黴漿菌)
FQ的抗菌範圍已經涵蓋非典型肺炎,所以FQ和macrolide通常不併用
(記:抗菌範圍FQ = β-lactam + macrolide)
4.下列何種藥品,較適合用於門診病人治療社區型肺炎感染?
(A)Ertapenem
(B)Cefepime
(C)Cefpirome
(D)Levofloxacin
------
5.下列何種藥品,不適合用於門診病人治療社區型肺炎感染?
(A)Piperacillin/tazobactam
(B)Amoxicillin/clavulanate
(C)Azithromycin
(D)Doxycycline
(A)Ampicillin
(B)Clindamycin
(C)Doxycycline
(D)Moxifloxacin
--------------------
CAP社區肺炎(Community-acquired pneumonia常見細菌抗生素治療
Streptococcus pneumoniae
若penicilin MIC < 2 ug/ml 建議使用Penicillin , Ampicllin or Amoxicillin
若penicilin MIC >4 ug/ml則考慮3° , 4° cephalosporins , Vancomycin or Teicoplanin
替代:New fluoroquinolones (Moxifloxacin, Levofloxacin 750mg/day,Gemifloxacin)
Haemophilus influenzae
β-lactamase (-) : Ampicillin or amoxicillin
β-lactamase (+) : Ampicillin/sulbactam , Amoxicillin/clavulanate ,2°cephalosporins
替代:New macrolides(Azithromycin) , TMP/SMX , 3° cephalosporins ,fluoroquinolones
Moraxella catarrhalis
首選:2° cephalosporins ,Ampicillin/sulbactam , Amoxicillin/clavulanate
替代:Erythromycin or new macrolidesc , 3° cephalosporins ,Fluoroquinolones
(Atypical CAP) Legionella spp. , Mycoplasma pneumoniae , Chlamydia pneumoniae
首選:Erythromycin or new macrolidesc , (Chlamydia可用Tetracyclines)
替代:Tetracyclines , Fluoroquinolones
HAP院內肺炎(Hospital-acquired pneumonia)常見細菌抗生素治療
考慮:GNB K. pneumoniae, P. aeruginosa , Acinetobacter spp.
首選:3° cephalosporinse(抗綠膿Ceftazidine) or Ureidopenicillins ±Aminoglycosidesf ±Erythromycin or new macrolide
替代:Timentin or Tazocin or 4°cephalosporins ±Aminoglycosidesf ±Erythromycin or new macrolide ,Fluoroquinolones
考慮:GPC MRSA
首選:Vancomycin Teicoplanin or Linezolid
其他
(for MDRAB) ±Sulbactam
(for MDRPA or MDRAB) ±Colistin
FQ單用
beta+macrolides
Severity: Major
Interaction Effect:
Concurrent use of MOXIFLOXACIN and SELECTED QT PROLONGING DRUGS may result in increased risk of QT-interval prolongation.

資料來源:micromedex drug interactions